BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 32227267)

  • 21. Overexpression of JAB1 promotes malignant behavior and predicts poor prognosis in esophageal squamous cell carcinoma.
    Shen Q; Shang B; Jiang B; Wang Y; Wang Z; Chen G
    Thorac Cancer; 2020 Apr; 11(4):973-982. PubMed ID: 32064781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHST15 promotes the proliferation of TE‑1 cells via multiple pathways in esophageal cancer.
    Wang X; Cheng G; Zhang T; Deng L; Xu K; Xu X; Wang W; Zhou Z; Feng Q; Chen D; Bi N; Wang L
    Oncol Rep; 2020 Jan; 43(1):75-86. PubMed ID: 31746400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
    Du F; Guo T; Cao C
    Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA PANDA promotes esophageal squamous carcinoma cell progress by dissociating from NF-YA but interact with SAFA.
    Shi W; Wang Q; Bian Y; Fan Y; Zhou Y; Feng T; Li Z; Cao X
    Pathol Res Pract; 2019 Oct; 215(10):152604. PubMed ID: 31495606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long noncoding RNA LSINCT5 is upregulated and promotes the progression of esophageal squamous cell carcinoma.
    Jing L; Lin J; Zhao Y; Liu GJ; Liu YB; Feng L; Yang HY; Cui WX; Zhang XH
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5195-5205. PubMed ID: 31298370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CircDUSP16 Contributes to Cell Development in Esophageal Squamous Cell Carcinoma by Regulating miR-497-5p/TKTL1 Axis.
    Ma L; Li H; Lin Y; Wang G; Xu Q; Chen Y; Xiao K; Rao X
    J Surg Res; 2021 Apr; 260():64-75. PubMed ID: 33326930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long non-coding RNA DUXAP8 regulates proliferation and invasion of esophageal squamous cell cancer.
    Xu LJ; Yu XJ; Wei B; Hui HX; Sun Y; Dai J; Chen XF
    Eur Rev Med Pharmacol Sci; 2018 May; 22(9):2646-2652. PubMed ID: 29771416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of DNMT1/hsa-miR-124-3p/BCAT1 pathway in regulating growth and invasion of esophageal squamous cell carcinoma.
    Zeng B; Zhang X; Zhao J; Wei Z; Zhu H; Fu M; Zou D; Feng Y; Luo H; Lei Y
    BMC Cancer; 2019 Jun; 19(1):609. PubMed ID: 31226958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of FBP1 promotes proliferation, migration, and invasion by regulating fatty acid metabolism in esophageal squamous cell carcinoma.
    He Y; Hua R; Li B; Gu H; Sun Y; Li Z
    Aging (Albany NY); 2020 Nov; 13(4):4986-4998. PubMed ID: 33232284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-14 (MMP-14) downregulation inhibits esophageal squamous cell carcinoma cell migration, invasion, and proliferation.
    Chen N; Zhang G; Fu J; Wu Q
    Thorac Cancer; 2020 Nov; 11(11):3168-3174. PubMed ID: 32930509
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma.
    Hu L; Wu Y; Tan D; Meng H; Wang K; Bai Y; Yang K
    J Exp Clin Cancer Res; 2015 Jan; 34(1):7. PubMed ID: 25613496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MiR-601 inhibits the proliferation and metastasis of esophageal squamous cell carcinoma (ESCC) by targeting HDAC6.
    Liu C; Tian X; Sun HB; Wang ZF; Jiang LF; Li ZX
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1069-1076. PubMed ID: 30779074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overexpression of U three protein 14a (UTP14a) is associated with poor prognosis of esophageal squamous cell carcinoma.
    Li KK; Mao CY; Zhang JG; Ma Q; Wang YJ; Liu XH; Bao T; Guo W
    Thorac Cancer; 2019 Nov; 10(11):2071-2080. PubMed ID: 31496055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD82/KAI1 inhibits invasion and metastasis of esophageal squamous cell carcinoma via TGF-β1.
    Zeng TD; Zheng B; Zheng W; Chen C
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5928-5937. PubMed ID: 30280774
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma.
    Zhao Y; Wang Y; Xing G
    Biomed Pharmacother; 2018 Oct; 106():1650-1660. PubMed ID: 30119241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. KCNJ15 Expression and Malignant Behavior of Esophageal Squamous Cell Carcinoma.
    Nakamura S; Kanda M; Koike M; Shimizu D; Umeda S; Hattori N; Hayashi M; Tanaka C; Kobayashi D; Yamada S; Omae K; Kodera Y
    Ann Surg Oncol; 2020 Jul; 27(7):2559-2568. PubMed ID: 32052303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The expression and role of TRPV2 in esophageal squamous cell carcinoma.
    Kudou M; Shiozaki A; Yamazato Y; Katsurahara K; Kosuga T; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
    Sci Rep; 2019 Nov; 9(1):16055. PubMed ID: 31690728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNF113A promotes the proliferation, migration and invasion, and is associated with a poor prognosis of esophageal squamous cell carcinoma.
    Wang L; Hou Z; Hasim A; Abuduerheman A; Zhang H; Niyaz M; Awut I; Upur H; Sheyhidin I
    Int J Oncol; 2018 Mar; 52(3):861-871. PubMed ID: 29393393
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA-NEF inhibits proliferation, migration and invasion of esophageal squamous-cell carcinoma cells by inactivating wnt/β-catenin pathway.
    Zhang J; Hu SL; Qiao CH; Ye JF; Li M; Ma HM; Wang JH; Xin SY; Yuan ZL
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6824-6831. PubMed ID: 30402846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.